Medicine & Life Sciences
HIV-1
100%
HIV
71%
Anti-Infective Agents
63%
SARS Virus
61%
Viruses
44%
Chikungunya virus
42%
Neutralizing Antibodies
40%
Reverse Transcriptase Inhibitors
40%
Belgium
33%
Vaccination
30%
Vaccines
29%
Disease Outbreaks
26%
T-Lymphocytes
25%
Democratic Republic of the Congo
24%
Coronavirus
24%
Zika Virus
24%
Antibodies
24%
Infection
24%
Dendritic Cells
24%
Messenger RNA
23%
Dapivirine
21%
Alphavirus
20%
Tropical Spastic Paraparesis
19%
Antibody Formation
18%
Arboviruses
17%
Severe Acute Respiratory Syndrome
17%
Antiviral Agents
16%
In Vitro Techniques
16%
Human T-lymphotropic virus 1
16%
Routine Diagnostic Tests
14%
Dengue
14%
AIDS Vaccines
14%
Dengue Virus
14%
Monocytes
14%
Aruba
14%
Immunoglobulin G
13%
Antigens
13%
Female Genitalia
13%
Neutralization Tests
13%
Mutation
12%
Culicidae
12%
Biomarkers
12%
Chikungunya Fever
12%
GP 140
12%
Spinal Cord Diseases
12%
Proteins
12%
Macaca
12%
RNA
11%
Genitalia
11%
Ebolavirus
11%
Epidemics
11%
Genotype
10%
Guinea-Bissau
10%
Gels
10%
Triazines
10%
Microbiota
10%
Peptides
10%
Peru
9%
Pharmaceutical Preparations
9%
Monoclonal Antibodies
9%
Virus Diseases
9%
Health Personnel
9%
Anti-HIV Agents
9%
Binding Sites
9%
Annual Reports
9%
Humoral Immunity
9%
Serologic Tests
8%
Virion
8%
Cytokines
8%
Ebola Hemorrhagic Fever
7%
Cohort Studies
7%
HLA Antigens
7%
Semen
7%
Allergy and Immunology
7%
Epitopes
7%
Safety
7%
Immunoglobulin M
7%
Primates
7%
Genes
7%
Foams and Jellies Vaginal Creams
7%
Transfection
7%
Yellow Fever
7%
Zika Virus Infection
7%
HIV Infections
7%
Therapeutics
7%
Filoviridae
6%
Viral Load
6%
Lactobacillus
6%
Congresses
6%
Bacterial Vaginosis
6%
Genome
6%
A549 Cells
6%
Virus Replication
6%
trimix
6%
Population
6%
Nicotinamide Phosphoribosyltransferase
6%
Usutu virus
6%
Serum
6%
Utopias
6%
Human immunodeficiency virus 1 reverse transcriptase
6%